Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-CYCLOSPORINE 0.05% EMULSION Resolved 2023-11-16 2023-11-23 210431
TEVA-CYCLOSPORINE 0.05% EMULSION Resolved 2023-12-07 2024-03-21 212730
TEVA-CYCLOSPORINE 0.05% EMULSION Actual shortage 2024-05-16 2024-05-16 228149
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2017-08-21 2017-09-19 19937
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2021-01-07 2021-02-25 131063
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2023-06-08 2023-07-05 194054
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2023-06-19 2023-10-03 195518
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2019-10-03 2020-04-02 95408
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2019-10-03 2020-03-26 95411
NOVAMOXIN 50MG GRANULES FOR SUSPENSION Resolved 2020-02-07 2020-06-11 105596
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2020-04-10 2020-04-23 111841
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2020-05-14 2020-06-04 115196
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-05-19 2022-07-01 160983
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-08-18 2022-09-08 167159
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-09-22 2024-02-14 169966
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-10-20 2024-02-14 172263
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-02-02 2023-07-05 183361
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-11-03 195109
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-10-11 195112
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-10-11 195207

Showing 461 to 480 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295

Showing 41 to 60 of 250